Related Experiment Videos
Noninvasive diagnostic testing of coronary artery disease in women
1Division of Cardiology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0124, USA.
Insights
Diagnosing coronary artery disease (CAD) in women requires careful consideration, as noninvasive tests show varying accuracy. Exercise echocardiography offers the highest diagnostic accuracy for women among stress tests.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Women's Health
Background:
- Noninvasive diagnostic testing for coronary artery disease (CAD) is less studied and accurate in women compared to men.
- Accurate diagnostic testing is vital for early detection and optimal management of CAD.
- Several noninvasive modalities exist, including ECG, echocardiography, nuclear perfusion imaging, and exercise/pharmacologic testing.
Purpose of the Study:
- To review the accuracy and utility of noninvasive diagnostic tests for coronary artery disease (CAD).
- To highlight the specific challenges and considerations for diagnosing CAD in women.
- To guide the selection of the most appropriate diagnostic method based on patient pretest likelihood.
Main Methods:
- Review of existing literature on noninvasive diagnostic modalities for CAD.
- Analysis of test accuracy, particularly in relation to patient sex and pretest likelihood.
- Comparison of diagnostic performance across various noninvasive testing strategies.
Main Results:
- Exercise electrocardiography is less accurate in women.
- Combining electrocardiography with imaging (echocardiography or SPECT) improves diagnostic accuracy.
- Exercise echocardiography demonstrates the highest diagnostic accuracy in women among exercise stress tests.
- Electron beam computed tomography shows promise for detecting coronary artery calcium but requires further validation.
Conclusions:
- The choice of noninvasive CAD testing depends on pretest likelihood, influenced by sex, age, and risk factors.
- Noninvasive tests are most valuable for intermediate pretest likelihood of CAD.
- Exercise echocardiography is recommended for women unable to achieve maximal exercise, alongside pharmacologic testing options.
Abstract:
Noninvasive diagnostic testing of coronary artery disease (CAD) is widely recognized as an area that is less studied and less accurate with regard to women than to men. Accurate and safe diagnostic testing constitutes the crucial link between early detection and optimal management of CAD. Many noninvasive diagnostic modalities are available to the clinician, including traditional electrocardiography, the relatively novel imaging of echocardiography, the emerging nuclear perfusion technology of electron beam computed tomography, exercise testing, and pharmacologic testing. The most accurate and cost-effective diagnostic method for patients depends on the patients' pretest likelihood of the disease as determined by factors such as sex, age, and cardiovascular risk factors. Noninvasive tests are most useful in the diagnosis of CAD in patients with intermediate pretest likelihood of CAD. Patients with low pretest likelihood of CAD with normal electrocardiograms may benefit from noninvasive tests or a watchful waiting strategy. Patients with a high pretest likelihood of CAD may benefit greatly from direct referral to coronary angiography. Among the noninvasive diagnostic methods, exercise electrocardiography is the most studied and least accurate with regard to women patients. Electrocardiography improves in accuracy when combined with imaging techniques such as echocardiography or nuclear single photon emission computed tomography. Combining data from all studies has shown that exercise echocardiography yields the highest diagnostic accuracy in women among all of the exercise stress tests. Patients who are unable to achieve maximal exercise capacity may undergo pharmacologic testing using dipyridamole or adenosine radionuclide perfusion or dobutamine echocardiography. Recent development of electron beam computed tomography accurately detects coronary artery calcium but has not been validated yet as a standard diagnostic test for CAD.